HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nonprofit Pharmaceutical Companies

451.659

+27.0456.37%

Number of Gainers:31

Number of Losers:1

Number of Flat:2

PE:- -

High:455.687

Open:425.923

Low:425.923

Close:424.614

Loading ...

BRIEF-Peijia Medical Gets NMPA Approval For Registration Application Of Stent

Suzhou Basecare Medical Gets Jiangsu Nod for Registration of Sperm Quality Analyzer

MT Newswires Live

Peijia Medical - Nmpa Approval for Registration Application of Yonflow Flow Diverting Stent

THOMSON REUTERS

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live

CStone Pharmaceuticals CEO Boosts Shareholding

MT Newswires Live

Ascentage Pharma Trustee Buys HK$1.8 Million Shares

MT Newswires Live

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live

BRIEF-Cstone Pharmaceuticals Announces Further Increase In Shareholding By CEO

CStone Pharmaceuticals - Further Increase in Shareholding by CEO and Executive Director

THOMSON REUTERS

CStone Pharmaceuticals - CEO Purchased 560,000 Shares From April 2 to 7 With Purchase Price per Share Ranging From HKD2.26 to HKD3.29

THOMSON REUTERS

SinoMab's SM17 Dermatitis Drug Achieves Endpoints in Phase 1B China Clinical Trial

MT Newswires Live

BRIEF-Suzhou Basecare Medical Receives Jiangsu MPA Approval For Sperm Quality Analyzer

Suzhou Basecare Medical Corp - Jiangsu Mpa Approval of Registration Application for Portable Sperm Quality Analyzer

THOMSON REUTERS

Antengene to Buy Back Up to HK$40 Million of Shares

MT Newswires Live

The Price Is Right For Everest Medicines Limited (HKG:1952) Even After Diving 26%

Simply Wall St.

BRIEF-Antengene Announces Intention To Conduct On-Market Share Repurchase

Antengene Corp - Intention to Conduct on-Market Share Repurchase

THOMSON REUTERS

Antengene Corp - to Repurchase Shares in Open Market From Time to Time at Maximum Aggregate Price of HK$40 Mln

THOMSON REUTERS

Peijia Medical Completes First Patient Treatment in Trial of Transcatheter Aortic Valve Replacement System

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1574/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":451.659,"timestamp":1745294399443,"preClose":424.61395,"halted":0,"volume":104465654,"delay":0,"changeRate":0.063693,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Noon Closed","change":27.045044,"latestTime":"04-22 12:00:00","open":425.9225,"high":455.68738,"low":425.9225,"amount":2111707317,"amplitude":0.070099,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745298000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745285400000,1745294400000],[1745298000000,1745308800000]],"pbRate":3.545304,"peRate":-21.142926,"turnoverRate":0.003983,"increases":31,"decrements":1,"flats":1,"marketCap":261028958400,"floatMarketCap":241493112704},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":455.68738,"amplitude":0.070099,"preClose":424.61395,"low":425.9225,"pbRate":"3.545304","latestPrice":451.659,"volume":104465654,"delay":0,"open":425.9225,"prevYearClose":331.1933,"prevWeekClose":424.614,"prevMonthClose":455.082,"prevQuarterClose":455.082,"fiveDayClose":418.61,"twentyDayClose":454.409,"sixtyDayClose":319.608,"secType":"PLATE","market":"HK","turnoverRate":0.003983,"peRate":-21.142926,"marketCap":261028958400,"floatMarketCap":241493112704,"timestamp":1745294399443,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":31,"down":1,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526839941","title":"BRIEF-Peijia Medical Gets NMPA Approval For Registration Application Of Stent","url":"https://stock-news.laohu8.com/highlight/detail?id=2526839941","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526839941?lang=en_us&edition=fundamental","pubTime":"2025-04-09 23:27","pubTimestamp":1744212434,"startTime":"0","endTime":"0","summary":"BRIEF-Peijia Medical Gets NMPA Approval For Registration Application Of StentApril 9 (Reuters) - Peijia Medical Ltd 9996.HK:NMPA APPROVAL FOR REGISTRATION APPLICATION OF YONFLOW FLOW DIVERTING STENTFurther company coverage: 9996.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM25R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2526352447","title":"Suzhou Basecare Medical Gets Jiangsu Nod for Registration of Sperm Quality Analyzer","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352447","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352447?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:13","pubTimestamp":1744197223,"startTime":"0","endTime":"0","summary":"Suzhou Basecare Medical  obtained registration approval for its portable sperm quality analyzer from Jiangsu Medical Products Administration, a Wednesday filing with the Hong Kong bourse said.The device is a consumer-oriented home-based live sperm detection device designed for male reproductive health.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1597","02170","BK1574","BK1222"],"gpt_icon":0},{"id":"2526351380","title":"Peijia Medical - Nmpa Approval for Registration Application of Yonflow Flow Diverting Stent","url":"https://stock-news.laohu8.com/highlight/detail?id=2526351380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526351380?lang=en_us&edition=fundamental","pubTime":"2025-04-09 18:41","pubTimestamp":1744195313,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM25R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09996","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2526378903","title":"Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2526378903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526378903?lang=en_us&edition=fundamental","pubTime":"2025-04-09 17:18","pubTimestamp":1744190288,"startTime":"0","endTime":"0","summary":"Hong Kong stocks reversed earlier losses to finish moderately higher on Wednesday, as sentiment improved on hopes that China will roll out fresh measures to shield the economy from US tariffs.The Hang","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1588","HK0000320223.HKD","HSI","LU1969619763.USD","02186","02833","09688","BK1576","LU0307460666.USD","BK1161","HK0000306701.USD","BK1500","LU2328871848.SGD","BK1574","HHImain","BK1191","513600","HK0000320264.USD","LU0588546209.SGD","HK0000306685.HKD","06955","BK1141","LU2488822045.USD","BK1606","06160","MCHmain","09966","01548","BK1583"],"gpt_icon":0},{"id":"2526339749","title":"CStone Pharmaceuticals CEO Boosts Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2526339749","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526339749?lang=en_us&edition=fundamental","pubTime":"2025-04-09 16:46","pubTimestamp":1744188396,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals  Chief Executive Officer Jianxin Yang increased his holding in the drug company by 560,000 shares, according to a Wednesday filing with the Hong Kong bourse.Yang purchased the shares at a price ranging from HK$2.26 to HK$3.29 apiece, the filing said.Since beginning in his role as CEO, Yang has bought 10,359,000 shares, or 5.46% of the total shareholding of CStone.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","02616"],"gpt_icon":0},{"id":"2526333472","title":"Ascentage Pharma Trustee Buys HK$1.8 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2526333472","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526333472?lang=en_us&edition=fundamental","pubTime":"2025-04-09 16:19","pubTimestamp":1744186755,"startTime":"0","endTime":"0","summary":"Ascentage Pharma's (HKG:6855) trustee purchased 50,000 shares at an average of HK$35.20 apiece under its restricted share unit scheme, according to a Tuesday filing with the Hong Kong bourse.The total consideration for the shares hit about HK$1.8 million, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2526996382","title":"Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2526996382","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526996382?lang=en_us&edition=fundamental","pubTime":"2025-04-09 15:25","pubTimestamp":1744183543,"startTime":"0","endTime":"0","summary":"Hong Kong pharmaceutical stocks fell on Wednesday after US President Donald Trump said his administration would soon implement \"a major tariff on pharmaceuticals\" from foreign nations.Trump made the remarks at a Republican event, suggesting the move will force drug companies to relocate their operations to the US, according to a USA Today report.While initially sparing pharmaceuticals from recent tariffs, Trump has indicated for months that the imported drug industry is a future target, the report said.The news sent shares of Hong Kong-listed drugmakers falling on Wednesday afternoon.Alphamab Oncology  led the decliners with an almost 6% fall, followed by Boan Biotech  with a 5% drop. Luye Pharma  slid 4.4%, while BeiGene  and Genscript Bio  retreated nearly 4%. Zai Lab  slipped 3%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000306701.USD","LU1969619763.USD","HK0000320223.HKD","BK1500","01548","BK1191","BK1588","BK1574","BK1141","BK1606","BK1583","09688","06955","BK1576","LU0588546209.SGD","LU2328871848.SGD","BK1161","LU2488822045.USD","09966","HK0000306685.HKD","LU0307460666.USD","02186","HK0000320264.USD","06160"],"gpt_icon":0},{"id":"2526381021","title":"BRIEF-Cstone Pharmaceuticals Announces Further Increase In Shareholding By CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2526381021","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526381021?lang=en_us&edition=fundamental","pubTime":"2025-04-09 15:01","pubTimestamp":1744182101,"startTime":"0","endTime":"0","summary":"BRIEF-Cstone Pharmaceuticals Announces Further Increase In Shareholding By CEO April 9  - CStone Pharmaceuticals 2616.HK:FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTORCEO PURCHASED 560,000 SHARES FROM APRIL 2 TO 7 WITH PURCHASE PRICE PER SHARE RANGING FROM HKD2.26 TO HKD3.29Further company coverage: 2616.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN05L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2526802897","title":"CStone Pharmaceuticals - Further Increase in Shareholding by CEO and Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2526802897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526802897?lang=en_us&edition=fundamental","pubTime":"2025-04-09 12:28","pubTimestamp":1744172937,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN05L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02616","BK1574"],"gpt_icon":0},{"id":"2526780233","title":"CStone Pharmaceuticals - CEO Purchased 560,000 Shares From April 2 to 7 With Purchase Price per Share Ranging From HKD2.26 to HKD3.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2526780233","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526780233?lang=en_us&edition=fundamental","pubTime":"2025-04-09 12:28","pubTimestamp":1744172937,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN05L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CStone Pharmaceuticals - CEO Purchased 560,000 Shares From April 2 to 7 With Purchase Price per Share Ranging From HKD2.26 to HKD3.29","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","02616"],"gpt_icon":0},{"id":"2525895225","title":"SinoMab's SM17 Dermatitis Drug Achieves Endpoints in Phase 1B China Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2525895225","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525895225?lang=en_us&edition=fundamental","pubTime":"2025-04-08 19:40","pubTimestamp":1744112418,"startTime":"0","endTime":"0","summary":"SinoMab BioScience's  phase 1B China clinical trial of its SM17 drug for moderate-to-severe atopic dermatitis reached its primary endpoints, according to a Monday filing with the Hong Kong bourse.The drug was well-tolerated during the 16-week trial and follow-up period and showed no serious adverse events, the filing said.SM17 also showed skin healing effects, while lower doses of the drug showed relief from pruritus or itching compared with those treated with a placebo, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1161","03681"],"gpt_icon":0},{"id":"2525386280","title":"BRIEF-Suzhou Basecare Medical Receives Jiangsu MPA Approval For Sperm Quality Analyzer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525386280","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525386280?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:26","pubTimestamp":1744107994,"startTime":"0","endTime":"0","summary":"BRIEF-Suzhou Basecare Medical Receives Jiangsu MPA Approval For Sperm Quality AnalyzerApril 8  - Suzhou Basecare Medical Corp Ltd 2170.HK:JIANGSU MPA APPROVAL OF REGISTRATION APPLICATION FOR PORTABLE SPERM QUALITY ANALYZERFurther company coverage: 2170.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM02R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1597","02170","BK1574","BK1222"],"gpt_icon":0},{"id":"2525644018","title":"Suzhou Basecare Medical Corp - Jiangsu Mpa Approval of Registration Application for Portable Sperm Quality Analyzer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525644018","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525644018?lang=en_us&edition=fundamental","pubTime":"2025-04-08 18:20","pubTimestamp":1744107633,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM02R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1597","BK1222","BK1574","02170"],"gpt_icon":0},{"id":"2525832279","title":"Antengene to Buy Back Up to HK$40 Million of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2525832279","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525832279?lang=en_us&edition=fundamental","pubTime":"2025-04-08 14:39","pubTimestamp":1744094341,"startTime":"0","endTime":"0","summary":"Antengene  will buy back up to 67,488,874 shares, or 10% of the entire shareholding of the drug company, according to a Tuesday filing with the Hong Kong bourse.The maximum aggregate price for the share repurchase is HK$40 million, the filing said.Antengene's shares rose 1% during Tuesday's afternoon trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06996","BK1191","BK1574","BK1583"],"gpt_icon":0},{"id":"2525852117","title":"The Price Is Right For Everest Medicines Limited (HKG:1952) Even After Diving 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525852117","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525852117?lang=en_us&edition=fundamental","pubTime":"2025-04-08 12:57","pubTimestamp":1744088241,"startTime":"0","endTime":"0","summary":"Everest Medicines Limited ( HKG:1952 ) shareholders won't be pleased to see that the share price has had a very rough...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/the-price-is-right-for-everest-medicines-limited-hkg1952-eve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","01952","BK1583","MDCO"],"gpt_icon":0},{"id":"2525300260","title":"BRIEF-Antengene Announces Intention To Conduct On-Market Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2525300260","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525300260?lang=en_us&edition=fundamental","pubTime":"2025-04-08 09:24","pubTimestamp":1744075463,"startTime":"0","endTime":"0","summary":"BRIEF-Antengene Announces Intention To Conduct On-Market Share RepurchaseApril 8  - Antengene Corp Ltd 6996.HK:INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASETO REPURCHASE SHARES IN OPEN MARKET FROM TIME TO TIME AT MAXIMUM AGGREGATE PRICE OF HK$40 MILLIONFurther company coverage: 6996.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QL1NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1583","BK1574","06996"],"gpt_icon":0},{"id":"2525907768","title":"Antengene Corp - Intention to Conduct on-Market Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2525907768","media":"THOMSON REUTERS","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525907768?lang=en_us&edition=fundamental","pubTime":"2025-04-08 06:08","pubTimestamp":1744063719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL1NG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","06996","BK1191"],"gpt_icon":0},{"id":"2525686077","title":"Antengene Corp - to Repurchase Shares in Open Market From Time to Time at Maximum Aggregate Price of HK$40 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2525686077","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525686077?lang=en_us&edition=fundamental","pubTime":"2025-04-08 06:08","pubTimestamp":1744063719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL1NG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","06996","BK1574","BK1583"],"gpt_icon":0},{"id":"2525021043","title":"Peijia Medical Completes First Patient Treatment in Trial of Transcatheter Aortic Valve Replacement System","url":"https://stock-news.laohu8.com/highlight/detail?id=2525021043","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525021043?lang=en_us&edition=fundamental","pubTime":"2025-04-07 21:13","pubTimestamp":1744031601,"startTime":"0","endTime":"0","summary":"Peijia Medical (HKG:9996) completed the first patient treatment of the first-in-man clinical trial of ReachTactile robotic-assisted transcatheter aortic valve replacement (TAVR) system on April 2, an ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09996","BK1574","BK1583","BK1100"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}